Table 2 Mean (SD) levels of premorbid daily nutrient intake in patients and controls.
| Patients with ALS patients (n = 132) | Controls (n = 220) | p Value | |
|---|---|---|---|
| Energy intake (MJ/day) | 12.3 (4.0) | 11.9 (4.3) | 0.40 |
| Total fat (g) | 135.2 (27.6) | 140.2 (30.2) | 0.12 |
| Saturated fat (g) | 51.2 (10.5) | 50.0 (8.6) | 0.24 |
| Monounsaturated fat (g) | 49.8 (17.2) | 52.5 (28.1) | 0.33 |
| Polyunsaturated fat (g) | 25.5 (10.5) | 29.3 (12.0) | 0.003 |
| Cholesterol (mg) | 314 (75) | 297 (91) | 0.07 |
| Flavonols (mg) | 24.4 (19.5) | 27.1 (19.1) | 0.20 |
| Lycopene (mg) | 4.6 (3.5) | 4.5 (3.6) | 0.68 |
| Glutamate (mg) | 826 (382) | 804 (347) | 0.58 |
| Vitamin C (mg) | 133 (69) | 145 (78) | 0.16 |
| Vitamin E (mg) | 17.8 (7.1) | 20.5 (9.2) | 0.004 |
| Riboflavin (mg) | 2.0 (0.5) | 2.0 (0.5) | 0.78 |
| Calcium (mg) | 1223 (452) | 1195 (383) | 0.53 |
| Phytoestrogens (mg) | 0.34 (1.3) | 0.89 (4.3) | 0.15 |
| Dietary supplements n (%) | 43 (33) | 78 (36) | 0.58 |
Values are energy adjusted according to the residual method.